Unternehmens-Analyse: CrowdStrike

Zusammenfassung

CrowdStrike (CRWD) is a cloud-native cybersecurity vendor built around the Falcon platform, sold primarily as subscription software. The company’s core competency is consolidating multiple security workloads (endpoint, identity, cloud, log management/SIEM, threat intelligence, and managed services) onto a single agent + data layer, monetized via module adoption and enterprise-scale platform deals. Revenue is predominantly recurring subscription, supported by multi-year contracts and deferred revenue dynamics; management also tracks ARR and net new ARR as key operating indicators (not GAAP revenue segments). (ir.crowdstrike.com) Market position remains “platform leader” in endpoint and broader XDR, with competitive advantages centered on (1) a large-scale telemetry dataset, (2) high gross margins typical of mature SaaS, and (3) cross-sell efficiency as customers expand module count. Recent filings highlight meaningful contracted demand visibility: as of July 31, 2026, CrowdStrike disclosed backlog of approximately $5.9B, while also noting backlog is not used internally as a key management metric and is not necessarily predictive of future revenue. (ir.crowdstrike.com) In the most recently reported quarter (ended July 31, 2026; Q2 FY27), third-party compiled financial summaries indicate revenue of about $1.47B (+~26% YoY) with gross margin in the mid-70% range and free cash flow of roughly $376M. (gainstreet.ai) Profitability remains mixed under GAAP (very high trailing P/E can be distorted by low GAAP EPS), while non-GAAP profitability and cash generation are the more relevant near-term valuation anchors for many investors. (finance.yahoo.com) Valuation screens remain elevated on sales-based multiples (e.g., P/S and EV/Revenue in the mid-30s per Yahoo Finance key statistics), implying the market is paying for sustained mid-20% growth plus continued margin expansion. (finance.yahoo.com) Over the last ~90 days, the most actionable “market data” developments are (a) the latest SEC 10-Q (filed Aug 27, 2026) confirming seasonality (net new ARR typically stronger in 2H, especially Q4) and providing updated operating context (headcount 11,706 as of July 31, 2026), and (b) continued positive sell-side stance: MarketScreener shows a BUY consensus from 53 analysts with an average target price of $246.65 vs last close ~$238 (as of Oct 22, 2026). (ir.crowdstrike.com) EUR framing: using USD/EUR ~0.8890 on Oct 22, 2026, the latest price of $237.94 implies ~€211.6 per share (spot conversion, not a traded EUR listing). (investing.com) Short- to medium-term outlook is primarily driven by (1) net new ARR re-acceleration vs deceleration, (2) durability of mid-70% gross margin while scaling next-gen SIEM/log workloads, and (3) whether operating leverage continues to improve without sacrificing growth.

Key Takeaways

1. Platform subscription model with strong recurring revenue characteristics; growth is driven by module expansion and enterprise platform adoption rather than discrete product sales. (ir.crowdstrike.com)
2. Latest reported quarter (ended July 31, 2026) shows ~mid-20% YoY revenue growth and mid-70% gross margin, consistent with a scaled cybersecurity SaaS profile. (gainstreet.ai)
3. Contracted demand visibility is sizable (backlog ~ $5.9B as of July 31, 2026), but management explicitly cautions backlog is not necessarily indicative of future revenue and is not a key internal metric. (ir.crowdstrike.com)
4. Valuation remains demanding on common screens (e.g., sales-based multiples in the mid-30s; very high trailing P/E due to low GAAP EPS), increasing sensitivity to any growth or margin disappointment. (finance.yahoo.com)
5. Street sentiment is constructive: MarketScreener shows a BUY consensus (53 analysts) with average target ~$246.65 vs ~$238 last close (Oct 22, 2026), implying modest upside on consensus targets at that timestamp. (marketscreener.com)

Action-Ideen

Contrarian Insights

• • Consensus is BUY, but the average target implied only low-single-digit upside at the Oct 22, 2026 close—suggesting the market may already be pricing in much of the near-term good news, leaving asymmetric downside if execution is merely “good” rather than “exceptional.” (marketscreener.com)
• • Backlog (~$5.9B) can look like strong forward visibility, yet the company explicitly states backlog is not a key internal metric and is not necessarily indicative of future revenue; a contrarian view is to discount backlog heavily and focus instead on net new ARR trajectory and cash conversion. (ir.crowdstrike.com)